{"id":"https://openalex.org/W2038500552","doi":"https://doi.org/10.1186/1750-1172-7-74","title":"Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?","display_name":"Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2038500552","doi":"https://doi.org/10.1186/1750-1172-7-74","mag":"2038500552","pmid":"https://pubmed.ncbi.nlm.nih.gov/23013790","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3582462"},"language":"en","primary_location":{"id":"doi:10.1186/1750-1172-7-74","doi":"https://doi.org/10.1186/1750-1172-7-74","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1750-1172-7-74","pdf_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/1750-1172-7-74","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/1750-1172-7-74","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002595270","display_name":"Wills Hughes-Wilson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137624","display_name":"Swedish Orphan Biovitrum (Sweden)","ror":"https://ror.org/04asvbz37","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210137624"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Wills Hughes-Wilson","raw_affiliation_strings":["EU Committee of Experts on Rare Diseases (EUCERD), Global Public Policy & Government Relations, SOBI - Swedish Orphan Biovitrum, Tomtebodv\u00e4gen, 23a, Solna, Sweden. wills.hughes-wilson@sobi.com","EU Committee of Experts on Rare Diseases (EUCERD), Global Public Policy & Government Relations, SOBI - Swedish Orphan Biovitrum, Tomtebodv\u00e4gen, 23a, Solna, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EU Committee of Experts on Rare Diseases (EUCERD), Global Public Policy & Government Relations, SOBI - Swedish Orphan Biovitrum, Tomtebodv\u00e4gen, 23a, Solna, Sweden. wills.hughes-wilson@sobi.com","institution_ids":["https://openalex.org/I4210137624"]},{"raw_affiliation_string":"EU Committee of Experts on Rare Diseases (EUCERD), Global Public Policy & Government Relations, SOBI - Swedish Orphan Biovitrum, Tomtebodv\u00e4gen, 23a, Solna, Sweden","institution_ids":["https://openalex.org/I4210137624"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ana Palma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana Palma","raw_affiliation_strings":["Market Access & Public Affairs, Shire Human Genetic Therapies, Lambroekstraat 5C, Diegem, B-1831, Belgium","SHIRE HUMAN GENETIC THERAPIES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Market Access & Public Affairs, Shire Human Genetic Therapies, Lambroekstraat 5C, Diegem, B-1831, Belgium","institution_ids":[]},{"raw_affiliation_string":"SHIRE HUMAN GENETIC THERAPIES","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063357430","display_name":"Ad Schuurman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ad Schuurman","raw_affiliation_strings":["Business Contact Centre & International Affairs, Dutch Health-Care Insurance Board (CVZ \u2013 College voor zorgverzekeringen), Eekholt 4, Diemen, XH, 1112, Netherlands","Dutch Health-Care Insurance Board (CVZ \u2013 College voor zorgverzekeringen)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Business Contact Centre & International Affairs, Dutch Health-Care Insurance Board (CVZ \u2013 College voor zorgverzekeringen), Eekholt 4, Diemen, XH, 1112, Netherlands","institution_ids":[]},{"raw_affiliation_string":"Dutch Health-Care Insurance Board (CVZ \u2013 College voor zorgverzekeringen)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047342188","display_name":"Steven Simoens","orcid":"https://orcid.org/0000-0002-9512-2005","observed_orcids":["https://orcid.org/0000-0002-9512-2005"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Steven Simoens","raw_affiliation_strings":["Pharmaco-economics Katholieke Universiteit Leuven, Research Centre for Pharmaceutical Care & Pharmaco-economics O&N2 Bus 521, Herestraat 49, Leuven, B-3000, Belgium","Research Centre for Pharmaceutical Care & Pharmaco-economics O&N2 Bus 521"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaco-economics Katholieke Universiteit Leuven, Research Centre for Pharmaceutical Care & Pharmaco-economics O&N2 Bus 521, Herestraat 49, Leuven, B-3000, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Research Centre for Pharmaceutical Care & Pharmaco-economics O&N2 Bus 521","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5002595270"],"corresponding_institution_ids":["https://openalex.org/I4210137624"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":30.4973,"has_fulltext":true,"cited_by_count":171,"citation_normalized_percentile":{"value":0.99595089,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"7","issue":"1","first_page":"74","last_page":"74"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.030899999663233757,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orphan-drugs","display_name":"orphan drugs","score":0.9909999966621399},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.7770000100135803},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.6940000057220459},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.7059999704360962},{"id":"https://openalex.org/keywords/reimbursement","display_name":"reimbursement","score":0.3709999918937683},{"id":"https://openalex.org/keywords/unmet-medical-needs","display_name":"unmet medical needs","score":0.722000002861023},{"id":"https://openalex.org/keywords/value-based-pricing","display_name":"value-based pricing","score":0.4000000059604645},{"id":"https://openalex.org/keywords/regulatory-incentives","display_name":"regulatory incentives","score":0.3569999933242798},{"id":"https://openalex.org/keywords/patient-access-to-treatment","display_name":"patient access to treatment","score":0.6740000247955322},{"id":"https://openalex.org/keywords/europe","display_name":"Europe","score":0.49300000071525574}],"concepts":[{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.9556865692138672},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.5573105812072754},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.44824206829071045},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.44220009446144104},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.38318589329719543},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.358266681432724},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.23097005486488342},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.12697046995162964},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1186/1750-1172-7-74","doi":"https://doi.org/10.1186/1750-1172-7-74","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1750-1172-7-74","pdf_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/1750-1172-7-74","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2579245","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3582462","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3582462","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3582462","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet J Rare Dis","raw_type":"Text"},{"id":"pmid:23013790","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23013790","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet journal of rare diseases","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:195614b700374cb8ab8a8223d454addd","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/195614b700374cb8ab8a8223d454addd","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Orphanet Journal of Rare Diseases, Vol 7, Iss 1, p 74 (2012)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1750-1172-7-74","doi":"https://doi.org/10.1186/1750-1172-7-74","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1750-1172-7-74","pdf_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/1750-1172-7-74","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.504800021648407}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2038500552.pdf","grobid_xml":"https://content.openalex.org/works/W2038500552.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1577652675","https://openalex.org/W1980519974","https://openalex.org/W1992253341","https://openalex.org/W1994634971","https://openalex.org/W2000046902","https://openalex.org/W2015121141","https://openalex.org/W2018148979","https://openalex.org/W2023560805","https://openalex.org/W2038492683","https://openalex.org/W2053785808","https://openalex.org/W2080029019","https://openalex.org/W2101535700","https://openalex.org/W2107886799","https://openalex.org/W2123407823","https://openalex.org/W2124811712","https://openalex.org/W2131080517","https://openalex.org/W2160488963","https://openalex.org/W2165663095","https://openalex.org/W2521207064","https://openalex.org/W4402730046"],"related_works":["https://openalex.org/W2006998604","https://openalex.org/W2080569997","https://openalex.org/W1990456425","https://openalex.org/W1973275534","https://openalex.org/W2201857448","https://openalex.org/W4200602822","https://openalex.org/W4236319896","https://openalex.org/W2160488963","https://openalex.org/W2397937540","https://openalex.org/W2329099255"],"abstract_inverted_index":{"Since":[0],"its":[1,476],"enactment":[2],"in":[3,26,66,111,133,164,193,393,492,539,569],"2000,":[4],"the":[5,13,60,86,104,121,130,165,175,194,205,207,222,225,233,265,277,300,307,324,353,365,375,380,383,388,398,404,435,452,461,468,473,484,490,520,523,527,540,556,566,572,586],"European":[6],"Orphan":[7,117],"Medicinal":[8],"Products":[9],"Regulation":[10],"has":[11,53,187,280],"allowed":[12],"review":[14],"and":[15,108,137,150,213,221,357,414,472,505,517,526,529,549,563],"approval":[16],"of":[17,37,85,97,177,191,204,210,224,267,302,326,355,367,371,377,400,445,460,489,522,574],"approaching":[18],"70":[19],"treatments":[20,47,61],"for":[21,48,81,264,286,342,588],"some":[22,444],"55":[23],"different":[24,260,462,557],"conditions":[25],"Europe.":[27],"Success":[28],"does":[29],"not":[30],"come":[31],"without":[32],"a":[33,82,268,327,340,503,511,531,552,575],"price,":[34],"however.":[35],"Many":[36],"these":[38,250,259],"so-called":[39],"\"orphan":[40],"drugs\"":[41],"have":[42,78],"higher":[43,308],"price":[44],"points":[45],"than":[46],"more":[49,396,512,532],"common":[50],"diseases.":[51],"This":[52,423],"been":[54,188,281],"raising":[55],"debate":[56],"as":[57,129,240,339,411],"to":[58,72,127,146,160,172,216,231,257,270,293,296,316,346,427,465,487,535,554,564],"whether":[59,387],"are":[62,101,119,153,158,180,314],"worth":[63],"it,":[64],"which,":[65],"turn":[67,258],"risks":[68],"blocking":[69],"patient":[70],"access":[71],"treatment.":[73],"To":[74],"date,":[75],"orphan":[76,98,162,178,195,211,242,273,303,312,350,430,561],"drugs":[77,118,163,179,212,274,304,313,562],"only":[79,442],"accounted":[80],"small":[83],"percentage":[84],"overall":[87],"drug":[88,196,351,431],"budget.":[89],"It":[90,279],"would":[91,337],"appear":[92],"that,":[93,247],"with":[94,113,140,407,519,571],"increasing":[95,189],"numbers":[96],"drugs,":[99],"governments":[100,138,152,171,345,426],"concerned":[102],"about":[103],"future":[105],"budget":[106],"impact":[107,378],"their":[109,214],"cost-effectiveness":[110,219,319],"comparison":[112],"other":[114,368,408,421],"healthcare":[115,147,470],"interventions.":[116],"under":[120,181],"spotlight,":[122],"something":[123],"that":[124,143,235,283,306,382,432,441,455,581],"is":[125],"likely":[126],"continue":[128],"economic":[131],"crisis":[132],"Europe":[134],"takes":[135],"hold":[136],"respond":[139],"austerity":[141],"measures":[142,416],"include":[144,361],"cuts":[145],"expenditures.":[148],"Formally":[149],"informally,":[151],"looking":[154],"at":[155,352,475],"how":[156],"they":[157],"going":[159],"handle":[161,555],"future.":[166],"Collaborative":[167],"proposals":[168],"between":[169,515],"EU":[170],"better":[173],"understand":[174],"value":[176,428,454],"consideration.":[182],"In":[183],"recent":[184],"years":[185],"there":[186],"criticism":[190],"behaviours":[192],"field,":[197],"mainly":[198],"centring":[199],"on":[200,332,379,458,483,495],"two":[201],"key":[202],"perceptions":[203],"system:":[206],"high":[208],"prices":[209],"inability":[215],"meet":[217,317],"standard":[218,284],"thresholds;":[220],"construct":[223],"system":[226,269,330,471,507],"itself,":[227],"which":[228,336],"allows":[229],"companies":[230],"gain":[232],"benefits":[234],"accrue":[236],"from":[237,439],"being":[238],"badged":[239],"an":[241,429],"drug.":[243],"The":[244,321,578],"authors":[245,322,579],"hypothesise":[246],"by":[248,311,403,418],"examining":[249],"criticisms":[251],"individually,":[252],"one":[253,394,440],"might":[254],"be":[255,294,391],"able":[256],"\"behaviours\"":[261],"into":[262,298],"criteria":[263,436,491],"creation":[266],"evaluate":[271,347],"new":[272,328,349,384,543,560],"coming":[275],"onto":[276],"market.":[278],"acknowledged":[282],"methodologies":[285],"Health":[287],"Technology":[288],"Assessments":[289],"(HTA)":[290],"will":[291,424,508],"need":[292],"tailored":[295],"take":[297],"account":[299],"specificities":[301],"given":[305],"price-points":[309],"claimed":[310],"unlikely":[315],"current":[318],"thresholds.":[320],"propose":[323],"development":[325],"assessment":[329],"based":[331,494],"several":[333],"evaluation":[334],"criteria,":[335,463],"serve":[338],"tool":[341,553],"Member":[343],"State":[344],"each":[348,459,479,488,497],"time":[354],"pricing":[356,548],"reimbursement.":[358],"These":[359],"should":[360],"rarity,":[362],"disease":[363],"severity,":[364],"availability":[366],"alternatives":[369],"(level":[370],"unmet":[372],"medical":[373],"need),":[374],"level":[376,399],"condition":[381],"treatment":[385],"offers,":[386],"product":[389],"can":[390],"used":[392],"or":[395,420],"indications,":[397],"research":[401],"undertaken":[402],"developer,":[405],"together":[406],"factors,":[409],"such":[410],"manufacturing":[412],"complexity":[413],"follow-up":[415],"required":[417],"regulatory":[419],"authorities.":[422],"allow":[425],"fulfilled":[433],"all":[434,589],"very":[437],"differently":[438],"met":[443],"them.":[446],"An":[447],"individual":[448,480,498],"country":[449],"could":[450,545],"determine":[451],"(monetary)":[453],"it":[456],"places":[457],"according":[464],"societal":[466],"preferences,":[467],"national":[469,567],"resources":[474],"disposal":[477],"-":[478],"government":[481],"deciding":[482],"weighting":[485],"attributed":[486],"question,":[493],"what":[496],"society":[499],"values":[500],"most.":[501],"Such":[502],"systematic":[504],"transparent":[506],"help":[509],"frame":[510],"structured":[513],"dialogue":[514],"manufacturers":[516],"payers,":[518],"involvement":[521],"treating":[524],"physicians":[525],"patients;":[528],"foster":[530],"certain":[533],"environment":[534],"stimulate":[536],"continued":[537],"investment":[538],"field.":[541],"A":[542],"approach":[544,587],"also":[546],"offer":[547],"reimbursement":[550],"decision-makers":[551],"characteristics":[558],"amongst":[559],"redistribute":[565],"budgets":[568],"accordance":[570],"outcome":[573],"differentiated":[576],"assessment.":[577],"believe":[580],"this":[582],"could,":[583],"therefore,":[584],"facilitate":[585],"stakeholders.":[590]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":18},{"year":2017,"cited_by_count":20},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}